President and Chief Executive Officer
Allan is President & Chief Executive Officer (CEO) of Apotex. In this role, Allan leads a global workforce of almost 8,000 employees and the operations of Apotex around the globe in more than 115 countries.
Allan brings four decades of experience in corporate leadership to Apotex, including 20 years in the pharmaceutical industry. Most recently, he served as CEO of Concordia International Corp. and CEO of Sagent Pharmaceuticals Inc. Prior to these positions, he served as President and CEO of Teva Canada (formerly Novopharm Limited), COO of Teva International Group, President of Teva EMIA and President and CEO of Teva Americas Generics. His extensive experience includes strategy development, transformational business growth, execution excellence, international market expansion and global partnerships.
Mr. Oberman has almost three decades of corporate governance experience, having served on numerous boards, including as Chairman of the Canadian Generic Pharmaceutical Association and Vice-Chairman of the U.S. Association for Accessible Medicines. He has an MBA from the Schulich School of Business, York University, and a BA from Western University.